FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis

17 Oct 2026 0 comments

Adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive now have a second self-administration option for the complement inhibitor zilucoplan.

Source: NeurologyLive Published 16 Oct 2026 Imported 17 Oct 2026

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment